Disease Overview：Tumor Ablation Therapy（TAT）
Tumor ablation therapy is a minimally invasive, image-guided intervention used primarily for localized solid tumors—particularly in the liver, kidney, lung, and bone—when surgical resection is contraindicated due to comorbidities, tumor location, or patient preference. Common modalities include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and irreversible electroporation (IRE). These techniques induce controlled thermal or non-thermal cell death within the tumor margin while preserving surrounding healthy tissue. Ablation is often employed as definitive treatment for early-stage hepatocellular carcinoma or renal cell carcinoma, or as palliative therapy for metastatic disease. Eligibility depends on tumor size (<5 cm), number (typically ≤3 lesions), anatomical accessibility, and adequate organ function. Outcomes are monitored via contrast-enhanced CT or MRI at regular intervals to assess complete ablation and detect local recurrence.
China offers compelling advantages for international patients seeking tumor ablation: its leading oncology centers—such as Fudan University Shanghai Cancer Center and Sun Yat-sen University Cancer Center—boast internationally trained interventional oncologists with extensive experience in complex ablations, including dual-modality and fusion-guided procedures. State-of-the-art equipment—including real-time ultrasound elastography, 3D navigation platforms, and next-generation MWA systems—is widely deployed and routinely updated. Clinical data demonstrate high technical success rates (>92%) and favorable 3-year local tumor control (78–85%) across major institutions. Crucially, costs remain 40–60% lower than in the US, UK, or Germany, without compromising safety or efficacy. As a dedicated medical tourism agency, we facilitate seamless access for international patients: coordinating appointments with certified specialists, verifying hospital accreditation and device certifications, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and travel logistics to post-procedure follow-up coordination and multilingual care navigation.
Tumor Ablation Therapy: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Tumor Ablation Therapy (Oncology Department)
Non-Surgical / Conservative Options
*Not applicable for primary tumor ablation.* Tumor ablation is inherently interventional; no medication or lifestyle regimen achieves localized tumor destruction. Supportive care (e.g., pain control, antiemetics) may accompany ablation but does not replace it. No ablation-specific conservative therapy exists.
Interventional Ablation Procedures (Oncology Department)
Eligibility: Solid tumors ≤5 cm, ≤3 lesions, non-resectable due to location/comorbidity, adequate organ function (e.g., INR <1.5, platelets >50×10⁹/L), confirmed histology.
- •Radiofrequency Ablation (RFA)
- Procedure (incl. imaging guidance, disposable electrode, anesthesia): $1,450–$2,100 - Post-procedure monitoring (24-hr admission, vitals, labs): $190–$270 *Total range: $1,920–$2,730*
- •Microwave Ablation (MWA)
- Procedure (higher-power generator, multi-probe capability): $1,850–$2,650 - Post-procedure monitoring: $190–$270 *Total range: $2,320–$3,280*
- •Cryoablation
- Procedure (cryoprobe system, argon/helium gas, intra-procedural CT monitoring): $2,200–$3,100 - Post-procedure monitoring (extended observation for freeze-thaw complications): $240–$330 *Total range: $2,760–$3,840*
Special/Complex Condition Options
- •Liver metastases (colorectal origin, ≤3 lesions, no extrahepatic disease): MWA preferred; add contrast-enhanced ultrasound fusion imaging ($380). Total: $2,700–$3,660
- •Renal cell carcinoma (T1a, solitary kidney): Cryoablation with real-time MRI thermometry ($520 add-on). Total: $3,280–$4,360
- •Lung ablation in severe COPD (FEV₁ <50% predicted): Requires pre-op pulmonary rehab + bronchoscopy ($460); RFA only. Total: $2,380–$3,190
Quick Selection Guide
- •Age ≥75 years, multiple comorbidities (CHF, CKD stage 3): RFA — lowest procedural risk and cost ($1,920–$2,730)
- •Budget-constrained (<$2,500 USD), liver/renal tumor ≤3 cm: RFA — optimal efficacy-to-cost ratio
- •Large or irregular tumor (3–5 cm), central liver lesion: MWA — superior heat sink resistance ($2,320–$3,280)
- •Young patient (<60), renal tumor in solitary kidney, or need for precise margin control: Cryoablation — real-time ice-ball visualization (–$3,840)
- •Metastatic colorectal cancer with oligometastatic liver disease: MWA + CEUS fusion imaging — highest local control rate ($2,700–$3,660)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Tumor Ablation Therapy Medical Vacation Packages
Curated transparent all-inclusive packages combining Tumor Ablation Therapy treatment with China top medical destinations:
